10 May, 2023
\n \n \n \nThe Kennedy professor is one of eight researchers from Oxford University who received a prestigious fellowship from the Royal Society in recognition of their work in the fields of science and medicine.
\n \n\n \n \n21 Apr, 2023
\n \n \n \nA recent study to test the feasibility of running a randomised controlled trial of hormone replacement therapy (HRT) for post-menopausal women with hand osteoarthritis, has produced positive results. The HOPE-e feasibility study paves the way for researchers to design a full trial.
\n \n\n \n \n31 Mar, 2023
\n \n \n \nA new study led by Oxford researchers has found vedolizumab can induce remission in patients who have chronic pouchitis after surgery for ulcerative colitis.
\n \n\n \n \n30 Mar, 2023
\n \n \n \nAccording to a new Oxford study, changing clinical practice for finger injuries in children could save the NHS \u00a3720,000 per year.
\n \n\n \n \n22 Feb, 2023
\n \n \n \nA new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.
\n \n\n \n \n16 Feb, 2023
\n \n \n \nKennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.
\n \n\n \n \n6 Feb, 2023
\n \n \n \nIn his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.
\n \n\n \n \n22 Dec, 2022
\n \n \n \nA new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in disease models.
\n \n\n \n \n6 Dec, 2022
\n \n \n \nA generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.
\n \n\n \n \n2 Dec, 2022
\n \n \n \nThe kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.
\n \n\n \n \n1 Dec, 2022
\n \n \n \nConrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England
\n \n\n \n \n30 Nov, 2022
\n \n \n \nAlex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation\u2019s sixth Emerging Leaders Prize.
\n \n\n \n \n15 Nov, 2022
\n \n \n \nResearchers at the Kennedy Institute of Rheumatology and Oxford Population Health\u2019s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren\u2019s disease.
\n \n\n \n \n25 Oct, 2022
\n \n \n \nThe UK\u2019s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.
\n \n\n \n \n19 Oct, 2022
\n \n \n \nWelcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.
\n \n\n \n \n17 Oct, 2022
\n \n \n \nHealth and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
\n \n\n \n \n11 Oct, 2022
\n \n \n \nThe Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.
\n \n\n \n \n8 Sep, 2022
\n \n \n \nTwo new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.
\n \n\n \n \n21 Jul, 2022
\n \n \n \nSince 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.
\n \n\n \n \n12 Jul, 2022
\n \n \n \nThe Kennedy Trust has announced Dr Stephen Simpson as its new Chief Executive Officer from 1 July 2022.
\n \n\n \n \n